Market Research Logo

US Cardiac Troponin Diagnostics Market, Forecast to 2021

US Cardiac Troponin Diagnostics Market, Forecast to 2021

Cardiac troponins help to diagnose nearly two-thirds of the patients in the diagnosis Acute Coronary Syndrome (ACS) who are missed out by Echocardiogram (ECG). ECG can detect only one-third of the patients with persistent ST-segment Elevation (STEMI), whereas cardiac troponins can distinguish patients without ST-segment elevation (NSTEACS; non-ST segment elevation ACS) who require a conservative Unstable Angina (UA) or early-invasive approach (NSTEMI).

In addition to significant pricing challenges, there is growing competition encouraged by the adoption of point-of-care devices at physician offices and hospitals. Although technicians and patients prefer point-of-care devices, physicians and hospitals are still slow in adopting these devices due to conventional mindset and cost. High-sensitivity troponins are the latest addition to troponin tests and have expanded the clinical application. With the recent Food and Drug Administration (FDA) approval of a high-sensitivity troponin assay from Roche, it is soon expected that many more competitors will try to secure FDA approval that will further intensify the competition.

In the US, troponin I and T faced a decline similar to other tests due to reimbursement cuts. However, the volume of tests used for troponin T has been increasing and will continue to do so for the next 5 years. Due to the implementation of the ACA, reimbursement cuts have resulted in increased pricing pressure on many of these lab tests. This is expected to continue for the next 5 years if the same systems are going to be used to reimburse tests. The Protecting Access to Medicare Act (PAMA) regulation is expected to impact the price of routine tests. This downward trend in pricing would impact manufacturers’ ability to be paid at the same rate for the cost of reagents.

Research Scope
The objective of this research is to establish an understanding of the market for cardiac biomarker Troponin used for the diagnosis of acute myocardial infarction. The research covers the revenue generated by the use of cardiac troponin tests for diagnosis of acute myocardial infarction.

Key Issues Addressed
What are the key healthcare trends that could impact the global cardiac biomarker diagnostics market?
What are the market drivers and restraints that are impacting market growth?
What are the unmet needs and opportunities for existing and emerging participants?
What are the segment shares of key market participants?
How are companies dealing with the challenges in the market space?
What are the future trends and how is the forecast scenario of Acute Myocardial infarction (AMI) biomarkers diagnostics in different regions?


  • Methodology
  • Executive Summary
    • Global Cardiac Troponin Market-Executive Summary
    • US Cardiac Troponins Market-Executive Summary
    • Western European Cardiac Troponins Market-Executive Summary
    • APAC Cardiac Troponins Market-Executive Summary
    • Scope and Segmentation
    • Key Questions This Study Will Answer
    • Market Engineering Measurements
    • Cardiac Diagnostics Industry Overview
    • Cardiac Biomarkers Diagnostics Overview
    • Executive Summary-3 Big Predictions
  • Forecasts and Discussion
    • Market Engineering Measurements
      • Table Total Cardiac Troponin Diagnostics Market: Market Engineering Measurements, Global, 2016
    • Forecast Methodology
    • Revenue Forecast
      • Table Total Cardiac Troponin Diagnostics Market: Revenue Forecast, Global, 2015-2021
    • Percent Revenue Breakdown by Segment-Lab-based Tests Versus POCT
    • Revenue Forecast by Segment
      • Table Total Cardiac Troponin Diagnostics Market: Revenue Forecast by Segment, Global, 2015-2021
    • Percent Revenue Forecast by Region
      • Table Total Cardiac Troponin Diagnostics Market: Percent Revenue Forecast by Region, Global, 2015- 2021
    • Revenue Forecast by Region
      • Table Total Cardiac Troponin Diagnostics Market: Revenue Forecast by Region, Global, 2015-2021
    • Percent of Revenue by Region
    • Revenue Forecast Discussion
  • Competitive Environment
    • Market Share
    • Market Share Analysis
      • Table Total Cardiac Troponin Diagnostics Market: Company Market Share Analysis of Top 5 Market Participants, Global, 2016
    • Top Competitors
  • Lab-based Tests Segment Analysis
    • Market Engineering Measurements
      • Table Lab-based Tests Segment: Market Engineering Measurements, Global, 2016
    • Revenue Forecast
      • Table Lab-based Tests Segment: Revenue Forecast, Global, 2015-2021
    • Revenue Forecast Discussion
    • Segment Share
    • Segment Share Analysis
      • Table Lab-based Tests Segment: Company Segment Share Analysis of Top 4 Participants, Global, 2016
  • POCT Segment Analysis
    • Market Engineering Measurements
      • Table POCT Segment: Market Engineering Measurements, Global, 2016
    • Revenue Forecast
      • Table POCT Segment: Revenue Forecast, Global, 2015-2021
    • Revenue Forecast Discussion
    • Segment Share
    • Segment Share Analysis
      • Table POCT Segment: Company Segment Share Analysis of Top 4 Participants, Global, 2016
  • Regional Analysis-US
    • Executive Summary
    • Scope and Segmentation
    • Key Questions This Study Will Answer
    • Market Engineering Measurements
    • CEO's Perspective
    • Key Companies to Watch
  • Market Overview
    • Market Background
    • Market Background-Prevalence Rate
      • Table Cardiac Troponin Diagnostics Market: Prevalence Rate, US, 2009-2020
    • Market Overview-Testing Procedure
    • Current Trends in US Troponin Market
    • Troponin Testing Locations
  • Competitive Playbook
    • New Market Opportunities
    • Competitive Structures
    • Product Portfolio
  • Drivers and Restraints
    • Market Drivers
    • Drivers Explained
    • Market Restraints
    • Restraints Explained
  • Forecasts and Discussion
    • Key Findings
      • Table Important Segment Characteristics
    • Forecast Methodology
    • Market Engineering Measurements
      • Table Cardiac Troponin Diagnostics Market: Market Engineering Measurements, US, 2016
    • Revenue Forecast
      • Table Cardiac Troponin Diagnostics Market: Revenue Forecast, US, 2015-2021
    • Revenue Forecast Discussion
    • Segment Breakdown
    • Revenue Forecast by Segment
      • Table Cardiac Troponin Diagnostics Market: Revenue Forecast by Segment, US, 2015-2021
    • US Lab-based Test Segment-Pricing Trends and Forecast
      • Table Lab-based Test Segment: Average Price for Lab-based Tests, US, 2015-2021
  • Competitive Environment
    • Market Share
    • Market Share Analysis
      • Table Cardiac Troponin Diagnostics Market: Company Market Share Analysis of Top 7 Participants, US, 2016
  • Growth Opportunity
    • Major Growth Opportunities
    • Growth Opportunity Matrix-Key Opportunities and Impact on Businesses
    • Growth Opportunity 1-Companion Diagnostics
    • Growth Opportunity 2-POCT in Cardiac Biomarker Diagnostics
    • Growth Opportunity 3-Integrated and Efficient System
    • Growth Opportunity 4-Digital Health and Diagnostics Inter- convergence Model
    • Strategic Imperatives for Success and Growth
  • Lab-based Segment Analysis
    • Key Findings
      • Table Important Segment Characteristics
    • Market Engineering Measurements
      • Table Lab-based Tests Segment: Market Engineering Measurements, US, 2016
    • Revenue Forecast
      • Table Lab-based Tests Segment: Revenue Forecast, US, 2015-2021
    • Revenue Forecast Discussion
    • Market Share
    • Market Share Analysis
      • Table Lab-based Tests Segment: Company Market Share Analysis of Top 4 Participants, US, 2016
  • POCT Segment Analysis
    • Key Findings
      • Table Important Segment Characteristics
    • Market Engineering Measurements
      • Table POCT Segment: Market Engineering Measurements, US, 2016
    • Revenue Forecast
      • Table POCT Segment: Revenue Forecast, US, 2015-2021
    • Revenue Forecast Discussion
    • Market Share
    • Market Share Analysis
      • Table POCT Segment: Company Market Share Analysis of Top 6 Participants, US, 2016
  • The Last Word
    • The Last Word-3 Big Predictions
  • Appendix
    • Market Engineering Methodology
    • List of Other Companies in Biomarkers Research, Development, and/or Services

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report